Morepen Laboratories Ltd. - Research Center
500288 MOREPENLAB Group (A) BSE data
Results
Statement
More
Mar ' 24 |
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Mar ' 20 |
Equity share capital
102.23 |
102.23 |
95.56 |
89.96 |
89.96 |
Share application money
Preference share capital
Reserves & surplus
786.80 |
677.89 |
502.61 |
311.26 |
217.29 |
Secured loans
28.19 |
25.16 |
18.57 |
59.90 |
12.28 |
Unsecured loans
Total
917.22 |
805.28 |
616.74 |
461.13 |
319.53 |
Gross block
474.71 |
496.81 |
470.18 |
512.78 |
628.45 |
Less : revaluation reserve
Less : accumulated depreciation
258.18 |
325.99 |
314.07 |
368.75 |
493.61 |
Net block
216.54 |
170.82 |
156.11 |
144.02 |
134.84 |
Capital work-in-progress
Investments
126.18 |
117.84 |
117.79 |
118.78 |
118.78 |
Current assets, loans & advances
912.14 |
799.86 |
745.21 |
582.74 |
408.37 |
Less : current liabilities & provisions
362.09 |
300.26 |
416.53 |
386.37 |
342.45 |
Total net current assets
550.05 |
499.60 |
328.69 |
196.37 |
65.91 |
Miscellaneous expenses not written
Total
917.22 |
805.28 |
616.74 |
461.13 |
319.53 |
Book value of unquoted investments
126.18 |
117.84 |
117.79 |
117.69 |
117.69 |
Market value of quoted investments
Contingent liabilities
20.04 |
11.84 |
18.98 |
3.36 |
1.27 |
Number of equity sharesoutstanding (Lacs)
5111.69 |
5111.69 |
4778.26 |
4498.26 |
4498.26 |